A groundbreaking shift in our drug policy has taken place, as the regulators permit the use of psilocybin mushrooms for therapeutic applications. Before this, these substances were severely restricted, but a growing body of research suggests they potentially offer relief for mental health conditions like depression. The new policy represents a subs